Surgery Partners, Inc. (NASDAQ:SGRY) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have received a consensus rating of “Moderate Buy” from the ten research firms that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $36.56.

Several equities analysts recently issued reports on SGRY shares. Royal Bank of Canada reduced their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 20th. JPMorgan Chase & Co. reduced their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 3rd. Macquarie reissued an “outperform” rating and set a $34.00 price objective on shares of Surgery Partners in a research note on Tuesday, November 19th. UBS Group began coverage on shares of Surgery Partners in a research note on Monday, October 14th. They set a “buy” rating and a $38.00 price objective on the stock. Finally, Bank of America began coverage on shares of Surgery Partners in a research note on Monday, December 16th. They set a “buy” rating and a $30.00 price target on the stock.

Surgery Partners Stock Down 0.5 %

Shares of NASDAQ SGRY opened at $25.65 on Friday. Surgery Partners has a 12-month low of $19.50 and a 12-month high of $35.29. The company has a market capitalization of $3.26 billion, a PE ratio of -53.44, a price-to-earnings-growth ratio of 17.66 and a beta of 2.60. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The firm’s 50-day moving average is $21.76 and its two-hundred day moving average is $26.99.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). The firm had revenue of $770.40 million for the quarter, compared to analysts’ expectations of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business’s quarterly revenue was up 14.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.15 EPS. Equities analysts anticipate that Surgery Partners will post 0.71 EPS for the current fiscal year.

Institutional Investors Weigh In On Surgery Partners

Several large investors have recently made changes to their positions in SGRY. Sei Investments Co. acquired a new stake in shares of Surgery Partners in the second quarter worth $699,000. Mackenzie Financial Corp increased its position in shares of Surgery Partners by 3.4% in the second quarter. Mackenzie Financial Corp now owns 19,999 shares of the company’s stock worth $476,000 after acquiring an additional 662 shares in the last quarter. Handelsbanken Fonder AB increased its position in shares of Surgery Partners by 35.1% in the third quarter. Handelsbanken Fonder AB now owns 18,100 shares of the company’s stock worth $584,000 after acquiring an additional 4,700 shares in the last quarter. Creative Planning acquired a new stake in shares of Surgery Partners in the third quarter worth $258,000. Finally, E. Ohman J or Asset Management AB increased its position in shares of Surgery Partners by 31.0% in the third quarter. E. Ohman J or Asset Management AB now owns 886,088 shares of the company’s stock worth $28,567,000 after acquiring an additional 209,888 shares in the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.